一例脑小叶发病的渐进性多焦点白内障 (PML) 与乙型肝炎相关的肝硬化病例
Kota Sato1, Akiko Saito1, Takeshi Miyazaki2
1Department of Neurology, Brain Attack Center Ota Memorial Hospital, Japan.
Internal medicine (Tokyo, Japan)
|November 12, 2025
概括
渐进性多焦点白内障 (PML) 可能发生在肝硬化患者中. 在MRI上早期识别半月形小脑病变对于及时诊断和治疗PML至关重要.
科学领域:
- 神经学 神经学
- 传染性疾病 传染性疾病
- 肝病学 肝病学是一种肝病学.
背景情况:
- 渐进性多焦点白内障 (PML) 是一种罕见的中枢神经系统脱髓化疾病.
- 它通常与严重的免疫抑制有关,通常在诸如艾滋病毒/艾滋病等疾病中或在使用免疫调节药物治疗期间出现.
- 与乙型肝炎相关的肝硬化可以导致相对免疫缺陷状态,增加对机会性感染的易感性.
研究的目的:
- 报告患有乙型肝炎相关肝硬化病例的PML病例.
- 在这种情况下,强调诊断挑战和关键的成像发现,暗示PML.
- 突出梅弗洛昆和米尔塔扎平在治疗PML中的潜在疗效.
主要方法:
- 一个70多岁的女性的病例报告,患有与乙型肝炎相关的肝硬化,出现小脑症状.
- 最初的诊断工作包括脑部的磁共振成像 (MRI).
- 通过重新评估脑活检和JC病毒 (JCV) 聚合酶连锁反应 (PCR) 分析脑脊液 (CSF) 来确认诊断.
主要成果:
- 这位患者出现了动脉和动脉障碍症,暗示大脑小脑干扰.
- 最初的MRI揭示了一个不对称的小脑白质病变,但PML诊断被推迟了.
- 脑脊液 (CSF) 分析证实了JC病毒 (JCV) 感染.
- 梅类药物和米尔塔扎类药物的治疗导致了CSF的病毒清除和临床稳定.
结论:
- 在MRI上半月形小脑病变应该引起对PML的怀疑,即使在没有明显严重免疫缺陷的患者中也是如此.
- 与乙型肝炎相关的肝硬化可能是导致PML的潜在疾病.
- 及时诊断和治疗,包括抗病毒治疗,对于管理PML和改善患者的治疗结果至关重要.
相关概念视频
Diseases of the Liver and Gallbladder
1.8K
Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
1.8K
Lysosomal Hydrolases
4.4K
Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
4.4K
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
171
In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...
171
Hepatic Portal System
5.2K
The hepatic portal system, a critical part of our circulatory framework, transports nutrient-laden, deoxygenated blood from the gastrointestinal tract and spleen to the liver. This ingenious system plays an indispensable role in maintaining our body's metabolic equilibrium.
At its core, the hepatic portal vein is the result of a confluence of the superior and inferior mesenteric veins along with the splenic vein. Each of these veins has a unique role. The superior mesenteric vein is...
At its core, the hepatic portal vein is the result of a confluence of the superior and inferior mesenteric veins along with the splenic vein. Each of these veins has a unique role. The superior mesenteric vein is...
5.2K


